Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06403345 · ClinicalTrials.gov registry record · NA

A Feasiblity Study of Green Activity Program for People Living With Memory Challenges

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06403345: Recruiting NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Indiana University.

NCT06403345 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06403345, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the Green Activity Program that was designed with people living with memory challenges and their study partners to see if it can be done and if they enjoy the program. "Green activities" are nature activities that the person enjoys and can be done with other people or pets. For example, dog walking, hiking, outdoor yoga, and gardening are all green activities. The purpose of the program is to help people living with memory challenges participate in nature activities they enjoy. The goal of the program is to help people stay active and improve their health and well-being.

Primary Outcome

intervention completion rate of 75%

Interventions

  • BEHAVIORAL Green Activity Program

Study Locations (1)

Indiana

  • Indiana University Bloomington - Bloomington

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-07-17
Est. Completion 2026-08-30
Phase NA
Indiana University

890 total trials

What NCT06403345 shows while recruiting

NCT06403345 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Green Activity Program is the first listed.

NCT06403345 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06403345 about?

NCT06403345 is a clinical study titled "A Feasiblity Study of Green Activity Program for People Living With Memory Challenges". The purpose of this study is to test the Green Activity Program that was designed with people living with memory challenges and their study partners to see if it can be done and if they enjoy the program. "Green activities" are nature activities that the person enjoys and can be done with other peop...

What is the current status of trial NCT06403345?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-07-17. Estimated completion is 2026-08-30.

What conditions does trial NCT06403345 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Subjective Cognitive Decline (SCD).

What interventions are being tested in trial NCT06403345?

The interventions under investigation include: Green Activity Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06403345?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06403345 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06403345's enrollment target sits among peer trials

40 221st of 306 higher than 74 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06403345, the US trial registry maintained by the National Library of Medicine. NCT06403345 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.